Skip to main content

Top Left Menu

  • Careers
  • Media

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Aesthetics
    • Consumer Care
    • Prescription Medicine
    • Global presence
    • Executive Committee
    • Governance
    • Annual Review 2021
  • Skin Stories
  • Skin Science
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • Our ESG roadmap
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
  • Media
  • Careers

Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction

Press release

Galderma expands footprint with new Global Capability Center in Barcelona to support global growth

Press release

IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio

Press release

"The Full Spectrum of Dermatology: A Diverse And Inclusive Atlas" Launches New, Free Online Image Gallery

Press release

Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products

Press release

Leading Acne Brand Launches First-Ever ​Retinoid Education Week

Press release

New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients

Press release

Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne

Press release

Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands

Press release

World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft

Press release

Pagination

  • Next page Next Page
Subscribe to Press release

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2023

Footer menu 2

  • Terms of use
  • Privacy
  • Cookie notice
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back